AOC, Drugs, Risk, and Publishers
Public funding is sometimes a start, but it's not what produces the products
More issues
Time for an Updated Ingelfinger Rule?
More journals not accepting preprints suggests new boundaries are forming
Interview with Brian O'Leary of BISG
On consolidation, standards, collaboration, and why "flat is the new up"
Rhyming & Marketing
What you've missed in the last month + a rhyming slogan
Science, Risks, and Geopolitics
The "Worldwide Threat Assessment" touches on science, tech, and scholarly publishing
Should Jeff Bezos Benefit from OA?
Taxpayer-funded research is the premise. What if a billionaire pays no taxes?
Are You There? Think Again
A guest post by Phaedra Cress explores how tech takes us away from reality
Framing Effects, OA, and the Impact Factor
A paper asserts IF = quality. Framing it differently may prove more informative.
Thanks for Sharing
You can help "The Geyser" where it matters the most
The Risks Haunting Preprints and Plan U
By focusing on scientists' needs, Plan U is positioned correctly. But it's carries risks.